| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaccinia virus | 6 | 2018 | 346 | 1.45 | Why? |
| HIV-1 | 9 | 2020 | 3365 | 1.39 | Why? |
| AIDS Vaccines | 3 | 2018 | 452 | 1.03 | Why? |
| SAIDS Vaccines | 2 | 2018 | 25 | 0.88 | Why? |
| Viral Envelope Proteins | 7 | 2017 | 3539 | 0.88 | Why? |
| Simian Immunodeficiency Virus | 3 | 2018 | 251 | 0.85 | Why? |
| HIV Antibodies | 5 | 2018 | 776 | 0.80 | Why? |
| Bone Morphogenetic Protein 1 | 1 | 2018 | 1 | 0.80 | Why? |
| Turbinates | 1 | 2021 | 205 | 0.80 | Why? |
| CD4-Positive T-Lymphocytes | 8 | 2020 | 4545 | 0.80 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 154 | 0.79 | Why? |
| HIV Infections | 9 | 2020 | 11620 | 0.77 | Why? |
| Vaccines, DNA | 5 | 2018 | 871 | 0.77 | Why? |
| fms-Like Tyrosine Kinase 3 | 1 | 2018 | 43 | 0.77 | Why? |
| Electrochemotherapy | 1 | 2018 | 10 | 0.76 | Why? |
| Electron Transport | 1 | 2018 | 20 | 0.76 | Why? |
| Integrin beta Chains | 1 | 2018 | 4 | 0.75 | Why? |
| Membrane Glycoproteins | 6 | 2010 | 2273 | 0.75 | Why? |
| Mitochondrial Dynamics | 1 | 2018 | 30 | 0.74 | Why? |
| Integrin alpha4 | 1 | 2018 | 21 | 0.74 | Why? |
| Acyltransferases | 1 | 2018 | 61 | 0.73 | Why? |
| Antigens, CD34 | 1 | 2018 | 125 | 0.73 | Why? |
| Osteogenesis | 1 | 2018 | 95 | 0.72 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 95 | 0.69 | Why? |
| Integrins | 1 | 2019 | 158 | 0.69 | Why? |
| Transforming Growth Factor beta1 | 2 | 2020 | 204 | 0.68 | Why? |
| Tuberculosis Vaccines | 1 | 2018 | 89 | 0.68 | Why? |
| Transduction, Genetic | 1 | 2018 | 273 | 0.67 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.66 | Why? |
| Dependovirus | 1 | 2018 | 272 | 0.66 | Why? |
| Osteosarcoma | 1 | 2017 | 83 | 0.65 | Why? |
| Virus Latency | 1 | 2018 | 251 | 0.61 | Why? |
| Antibodies, Bispecific | 1 | 2018 | 207 | 0.61 | Why? |
| Mutant Proteins | 1 | 2017 | 328 | 0.60 | Why? |
| Single-Chain Antibodies | 1 | 2018 | 259 | 0.60 | Why? |
| MicroRNAs | 3 | 2018 | 1787 | 0.59 | Why? |
| Carcinoma, Non-Small-Cell Lung | 3 | 2019 | 896 | 0.59 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.58 | Why? |
| Mucous Membrane | 1 | 2017 | 305 | 0.58 | Why? |
| Genetic Vectors | 3 | 2018 | 1600 | 0.54 | Why? |
| CD8-Positive T-Lymphocytes | 5 | 2020 | 5837 | 0.54 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.54 | Why? |
| Bone Neoplasms | 1 | 2017 | 287 | 0.53 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.53 | Why? |
| Immunity, Mucosal | 1 | 2017 | 426 | 0.53 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.53 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.52 | Why? |
| Mice, Inbred BALB C | 12 | 2021 | 5814 | 0.51 | Why? |
| SARS Virus | 12 | 2020 | 13021 | 0.51 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.51 | Why? |
| Stem Cell Transplantation | 1 | 2018 | 531 | 0.50 | Why? |
| Stem Cells | 1 | 2018 | 595 | 0.49 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.47 | Why? |
| Myasthenia Gravis | 1 | 2018 | 385 | 0.47 | Why? |
| Intestines | 2 | 2021 | 817 | 0.47 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2019 | 830 | 0.46 | Why? |
| Mitochondria | 2 | 2018 | 857 | 0.46 | Why? |
| Salivary Ducts | 1 | 2011 | 19 | 0.46 | Why? |
| Animals | 39 | 2021 | 78931 | 0.45 | Why? |
| Dendritic Cells | 1 | 2020 | 1330 | 0.45 | Why? |
| Amino Acid Substitution | 2 | 2017 | 1706 | 0.44 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.41 | Why? |
| Anti-Retroviral Agents | 1 | 2019 | 1099 | 0.41 | Why? |
| Mesocricetus | 5 | 2021 | 1847 | 0.40 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.39 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.38 | Why? |
| Smallpox Vaccine | 2 | 2009 | 46 | 0.38 | Why? |
| Lung Neoplasms | 4 | 2019 | 3228 | 0.38 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Homosexuality, Male | 1 | 2018 | 1158 | 0.37 | Why? |
| Arthroscopy | 2 | 2018 | 46 | 0.35 | Why? |
| Macaca mulatta | 4 | 2018 | 3716 | 0.35 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.35 | Why? |
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2017 | 29 | 0.34 | Why? |
| Vaccines, Attenuated | 2 | 2010 | 952 | 0.34 | Why? |
| Mice | 18 | 2021 | 21357 | 0.33 | Why? |
| Carcinoma, Hepatocellular | 4 | 2017 | 1222 | 0.33 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.33 | Why? |
| Plant Extracts | 1 | 2018 | 1514 | 0.32 | Why? |
| Chiroptera | 1 | 2021 | 3530 | 0.31 | Why? |
| Immunogenicity, Vaccine | 2 | 2018 | 4624 | 0.30 | Why? |
| Immunologic Memory | 1 | 2018 | 3362 | 0.30 | Why? |
| Immunologic Factors | 2 | 2019 | 4206 | 0.29 | Why? |
| Disease Models, Animal | 7 | 2021 | 10998 | 0.29 | Why? |
| Liver Neoplasms | 4 | 2017 | 1666 | 0.29 | Why? |
| Cells, Cultured | 3 | 2020 | 5835 | 0.26 | Why? |
| Antibody Formation | 1 | 2017 | 4038 | 0.25 | Why? |
| Cricetinae | 5 | 2021 | 3344 | 0.25 | Why? |
| HEK293 Cells | 7 | 2021 | 8394 | 0.25 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2017 | 511 | 0.25 | Why? |
| Antibodies, Monoclonal | 3 | 2020 | 8041 | 0.24 | Why? |
| Lupus Erythematosus, Systemic | 3 | 2018 | 1380 | 0.24 | Why? |
| Viral Tropism | 1 | 2010 | 1329 | 0.23 | Why? |
| HIV | 2 | 2018 | 1116 | 0.21 | Why? |
| ortho-Aminobenzoates | 1 | 2020 | 46 | 0.21 | Why? |
| Epithelial Cells | 2 | 2011 | 3508 | 0.21 | Why? |
| Sequence Deletion | 2 | 2020 | 674 | 0.21 | Why? |
| Cinnamates | 1 | 2020 | 50 | 0.21 | Why? |
| Spike Glycoprotein, Coronavirus | 13 | 2021 | 37182 | 0.21 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 9335 | 0.21 | Why? |
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 88 | 0.21 | Why? |
| Virus Attachment | 3 | 2021 | 1259 | 0.21 | Why? |
| Patellar Dislocation | 1 | 2019 | 1 | 0.20 | Why? |
| Orthomyxoviridae Infections | 2 | 2017 | 1001 | 0.20 | Why? |
| Neutralization Tests | 9 | 2021 | 6698 | 0.20 | Why? |
| Osteotomy | 1 | 2019 | 30 | 0.20 | Why? |
| Severe Acute Respiratory Syndrome | 6 | 2021 | 12361 | 0.20 | Why? |
| Transdermal Patch | 1 | 2019 | 52 | 0.19 | Why? |
| Sialic Acids | 1 | 2021 | 218 | 0.19 | Why? |
| Proline | 1 | 2021 | 345 | 0.19 | Why? |
| Fatty Alcohols | 1 | 2018 | 24 | 0.19 | Why? |
| Rats, Inbred Lew | 1 | 2018 | 45 | 0.19 | Why? |
| Catechols | 1 | 2018 | 43 | 0.19 | Why? |
| Tibial Meniscus Injuries | 1 | 2018 | 6 | 0.19 | Why? |
| Mice, Inbred NOD | 1 | 2018 | 134 | 0.19 | Why? |
| Phenylpropionates | 1 | 2019 | 68 | 0.19 | Why? |
| Mice, SCID | 1 | 2019 | 225 | 0.19 | Why? |
| Contracture | 1 | 2018 | 14 | 0.19 | Why? |
| Carbonic Anhydrase IV | 1 | 2017 | 2 | 0.18 | Why? |
| Conversion to Open Surgery | 1 | 2018 | 35 | 0.18 | Why? |
| Immunotherapy, Active | 1 | 2018 | 19 | 0.18 | Why? |
| Buttocks | 1 | 2018 | 34 | 0.18 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.18 | Why? |
| Species Specificity | 2 | 2018 | 1356 | 0.18 | Why? |
| Arginine | 1 | 2021 | 377 | 0.18 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 907 | 0.18 | Why? |
| Protein Structure, Tertiary | 4 | 2008 | 1565 | 0.18 | Why? |
| Gene Rearrangement | 1 | 2018 | 84 | 0.18 | Why? |
| Oncogene Proteins, Fusion | 1 | 2018 | 52 | 0.18 | Why? |
| Periplaneta | 1 | 2017 | 1 | 0.18 | Why? |
| Aldehyde Dehydrogenase | 1 | 2017 | 13 | 0.18 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 2 | 2017 | 349 | 0.18 | Why? |
| Phosphoinositide Phospholipase C | 1 | 2017 | 2 | 0.18 | Why? |
| Receptors, CCR | 1 | 2017 | 26 | 0.18 | Why? |
| Cell Line | 8 | 2020 | 12040 | 0.18 | Why? |
| Major Histocompatibility Complex | 1 | 2018 | 70 | 0.18 | Why? |
| Hip Joint | 1 | 2018 | 59 | 0.18 | Why? |
| Anti-Ulcer Agents | 1 | 2017 | 24 | 0.18 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.18 | Why? |
| Protein C Deficiency | 1 | 2017 | 18 | 0.18 | Why? |
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 31 | 0.17 | Why? |
| Fluoresceins | 1 | 2017 | 46 | 0.17 | Why? |
| Beclin-1 | 1 | 2017 | 38 | 0.17 | Why? |
| Cyclin-Dependent Kinases | 1 | 2017 | 124 | 0.17 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.17 | Why? |
| Hepatitis B e Antigens | 1 | 2017 | 99 | 0.17 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.17 | Why? |
| Prothrombin | 1 | 2018 | 149 | 0.17 | Why? |
| Hydrogels | 1 | 2019 | 173 | 0.17 | Why? |
| Receptors, Notch | 1 | 2017 | 59 | 0.17 | Why? |
| Mitochondrial Proteins | 1 | 2018 | 152 | 0.17 | Why? |
| Astroviridae | 1 | 2017 | 57 | 0.17 | Why? |
| Materia Medica | 1 | 2017 | 30 | 0.17 | Why? |
| Transcription Factor RelA | 1 | 2017 | 122 | 0.17 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 238 | 0.17 | Why? |
| Platinum | 1 | 2016 | 54 | 0.17 | Why? |
| Catalase | 1 | 2017 | 97 | 0.17 | Why? |
| Codon | 1 | 2018 | 287 | 0.17 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.16 | Why? |
| alpha-Fetoproteins | 1 | 2017 | 72 | 0.16 | Why? |
| Astroviridae Infections | 1 | 2017 | 56 | 0.16 | Why? |
| Stomach Ulcer | 1 | 2017 | 101 | 0.16 | Why? |
| Mutation | 4 | 2021 | 12376 | 0.16 | Why? |
| Cyclohexenes | 1 | 2016 | 9 | 0.16 | Why? |
| Allyl Compounds | 1 | 2016 | 7 | 0.16 | Why? |
| Lipogenesis | 1 | 2016 | 49 | 0.16 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.16 | Why? |
| Mice, Transgenic | 3 | 2018 | 2739 | 0.16 | Why? |
| Joint Diseases | 1 | 2018 | 122 | 0.16 | Why? |
| Thrombomodulin | 1 | 2017 | 121 | 0.16 | Why? |
| Diabetic Cardiomyopathies | 1 | 2017 | 79 | 0.16 | Why? |
| Staining and Labeling | 1 | 2017 | 169 | 0.16 | Why? |
| Rodent Diseases | 1 | 2017 | 115 | 0.16 | Why? |
| Protein C | 1 | 2017 | 141 | 0.16 | Why? |
| Graphite | 2 | 2017 | 318 | 0.16 | Why? |
| Aldehydes | 1 | 2016 | 56 | 0.16 | Why? |
| Surgical Flaps | 1 | 2018 | 188 | 0.15 | Why? |
| Humans | 55 | 2021 | 930598 | 0.15 | Why? |
| Microtubule-Associated Proteins | 1 | 2017 | 187 | 0.15 | Why? |
| Lipopolysaccharides | 2 | 2017 | 848 | 0.15 | Why? |
| Virulence | 4 | 2021 | 2172 | 0.15 | Why? |
| Recombination, Genetic | 2 | 2018 | 1265 | 0.15 | Why? |
| Proto-Oncogene Proteins | 1 | 2018 | 340 | 0.15 | Why? |
| Spleen | 2 | 2018 | 877 | 0.15 | Why? |
| Gold | 2 | 2017 | 592 | 0.15 | Why? |
| Prostate-Specific Antigen | 1 | 2016 | 213 | 0.15 | Why? |
| Immunohistochemistry | 3 | 2017 | 2275 | 0.15 | Why? |
| Adipocytes | 1 | 2016 | 173 | 0.15 | Why? |
| Phylogeny | 3 | 2018 | 13341 | 0.15 | Why? |
| Cross Reactions | 1 | 2007 | 4374 | 0.15 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2017 | 192 | 0.15 | Why? |
| Molecular Sequence Data | 4 | 2008 | 3198 | 0.14 | Why? |
| Camelids, New World | 1 | 2016 | 276 | 0.14 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 230 | 0.14 | Why? |
| Recombinant Fusion Proteins | 2 | 2017 | 919 | 0.14 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2020 | 1267 | 0.14 | Why? |
| Nitriles | 2 | 2017 | 1053 | 0.14 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.14 | Why? |
| Primates | 1 | 2018 | 584 | 0.14 | Why? |
| Female | 32 | 2021 | 380317 | 0.14 | Why? |
| Cross Protection | 1 | 2017 | 373 | 0.14 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.14 | Why? |
| Amino Acid Sequence | 6 | 2020 | 6049 | 0.13 | Why? |
| Vaccines, Virus-Like Particle | 1 | 2017 | 312 | 0.13 | Why? |
| Beijing | 1 | 2017 | 912 | 0.13 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2017 | 316 | 0.13 | Why? |
| Inhalation Exposure | 1 | 2018 | 405 | 0.13 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 372 | 0.13 | Why? |
| Models, Molecular | 6 | 2020 | 7616 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Thrombotic Microangiopathies | 1 | 2017 | 335 | 0.13 | Why? |
| Male | 30 | 2021 | 367725 | 0.13 | Why? |
| Receptors, IgG | 1 | 2017 | 578 | 0.13 | Why? |
| Fluorescent Dyes | 1 | 2017 | 536 | 0.13 | Why? |
| Copper | 1 | 2016 | 288 | 0.13 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 952 | 0.13 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2017 | 492 | 0.13 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2011 | 9659 | 0.13 | Why? |
| Osteoporosis | 1 | 2018 | 410 | 0.13 | Why? |
| Myalgia | 1 | 2019 | 1015 | 0.12 | Why? |
| Viral Vaccines | 3 | 2010 | 7560 | 0.12 | Why? |
| Hepatitis B virus | 2 | 2017 | 882 | 0.12 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2017 | 691 | 0.12 | Why? |
| Receptors, Virus | 3 | 2021 | 5659 | 0.12 | Why? |
| Electrochemical Techniques | 1 | 2016 | 406 | 0.12 | Why? |
| Treatment Outcome | 9 | 2019 | 51732 | 0.12 | Why? |
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1014 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.12 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Drug Carriers | 1 | 2018 | 590 | 0.12 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.12 | Why? |
| Biological Evolution | 1 | 2018 | 641 | 0.12 | Why? |
| Paeonia | 1 | 2010 | 7 | 0.11 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.11 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.11 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Administration, Intravaginal | 1 | 2010 | 38 | 0.11 | Why? |
| Animal Structures | 1 | 2010 | 61 | 0.11 | Why? |
| Signal Transduction | 4 | 2017 | 7207 | 0.11 | Why? |
| Immunization | 2 | 2018 | 2019 | 0.10 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.10 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.10 | Why? |
| Interleukin-17 | 1 | 2015 | 602 | 0.10 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.10 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.10 | Why? |
| Recombinant Proteins | 2 | 2017 | 3786 | 0.10 | Why? |
| Interferon-gamma | 2 | 2018 | 2711 | 0.10 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.10 | Why? |
| Proteins | 1 | 2017 | 921 | 0.10 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.10 | Why? |
| Rituximab | 1 | 2017 | 1096 | 0.10 | Why? |
| Retroviridae Proteins | 1 | 2008 | 5 | 0.09 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.09 | Why? |
| Virus Replication | 5 | 2021 | 14331 | 0.09 | Why? |
| Influenza A virus | 2 | 2020 | 2234 | 0.09 | Why? |
| Gene Expression Regulation | 2 | 2018 | 4020 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.09 | Why? |
| In Situ Hybridization | 1 | 2010 | 390 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 3 | 2017 | 3607 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Carboxypeptidases | 2 | 2005 | 148 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
| Epitope Mapping | 2 | 2020 | 1240 | 0.09 | Why? |
| Adult | 15 | 2020 | 244371 | 0.09 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.09 | Why? |
| Cell Line, Tumor | 3 | 2021 | 3608 | 0.09 | Why? |
| Anemia, Iron-Deficiency | 1 | 2010 | 210 | 0.09 | Why? |
| Disease Susceptibility | 2 | 2018 | 4002 | 0.08 | Why? |
| Injections, Intramuscular | 1 | 2010 | 800 | 0.08 | Why? |
| Microscopy | 1 | 2011 | 414 | 0.08 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2008 | 368 | 0.08 | Why? |
| Middle Aged | 15 | 2020 | 270681 | 0.08 | Why? |
| Helicobacter Infections | 1 | 2010 | 216 | 0.08 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.08 | Why? |
| Helicobacter pylori | 1 | 2010 | 262 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Madin Darby Canine Kidney Cells | 2 | 2020 | 640 | 0.08 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Knee Joint | 2 | 2019 | 194 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Biosensing Techniques | 2 | 2017 | 2116 | 0.08 | Why? |
| Glucosides | 1 | 2010 | 359 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Vaccinia | 1 | 2005 | 32 | 0.08 | Why? |
| Base Sequence | 2 | 2020 | 3581 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Sequence Homology, Amino Acid | 1 | 2008 | 945 | 0.07 | Why? |
| Administration, Intranasal | 1 | 2010 | 1132 | 0.07 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.07 | Why? |
| Vaccines, Synthetic | 1 | 2018 | 3231 | 0.07 | Why? |
| Vero Cells | 5 | 2021 | 14117 | 0.07 | Why? |
| Apoptosis | 2 | 2017 | 2335 | 0.07 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 436 | 0.07 | Why? |
| Medicine, Chinese Traditional | 1 | 2017 | 2255 | 0.07 | Why? |
| Immunization, Passive | 2 | 2018 | 10067 | 0.07 | Why? |
| Mutagenesis, Site-Directed | 1 | 2005 | 449 | 0.07 | Why? |
| Cluster Analysis | 2 | 2017 | 3001 | 0.07 | Why? |
| Biomarkers, Tumor | 3 | 2018 | 1314 | 0.07 | Why? |
| Promoter Regions, Genetic | 1 | 2008 | 823 | 0.07 | Why? |
| Aged | 10 | 2020 | 215776 | 0.07 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.07 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.07 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.07 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.06 | Why? |
| Kinetics | 2 | 2018 | 3238 | 0.06 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.06 | Why? |
| Young Adult | 7 | 2019 | 93724 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 7868 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2005 | 635 | 0.06 | Why? |
| Microscopy, Electron | 1 | 2005 | 830 | 0.06 | Why? |
| Time Factors | 5 | 2018 | 31397 | 0.06 | Why? |
| Substance-Related Disorders | 1 | 2017 | 2038 | 0.06 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.06 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 552 | 0.06 | Why? |
| Epitopes | 4 | 2021 | 4113 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Sequence Alignment | 1 | 2008 | 2109 | 0.06 | Why? |
| Virus Assembly | 1 | 2005 | 438 | 0.06 | Why? |
| Aerosols | 1 | 2018 | 5393 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 11367 | 0.06 | Why? |
| Immunoassay | 1 | 2017 | 4485 | 0.06 | Why? |
| Rabbits | 1 | 2005 | 1171 | 0.05 | Why? |
| Dogs | 2 | 2020 | 2529 | 0.05 | Why? |
| Blotting, Western | 2 | 2017 | 863 | 0.05 | Why? |
| Fibroblasts | 1 | 2005 | 839 | 0.05 | Why? |
| Organ Specificity | 1 | 2005 | 1070 | 0.05 | Why? |
| China | 4 | 2019 | 50654 | 0.05 | Why? |
| Influenza Vaccines | 1 | 2017 | 2941 | 0.05 | Why? |
| Plasmids | 2 | 2017 | 840 | 0.05 | Why? |
| Patella | 1 | 2019 | 23 | 0.05 | Why? |
| Antigens, Viral | 3 | 2006 | 6298 | 0.05 | Why? |
| Antineoplastic Agents | 2 | 2018 | 3550 | 0.05 | Why? |
| Weight Loss | 1 | 2005 | 826 | 0.05 | Why? |
| Genes, Viral | 1 | 2005 | 1428 | 0.05 | Why? |
| Immune System | 1 | 2009 | 1479 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Heparitin Sulfate | 1 | 2021 | 285 | 0.05 | Why? |
| Limit of Detection | 2 | 2017 | 2698 | 0.05 | Why? |
| Enzyme Precursors | 1 | 2018 | 7 | 0.05 | Why? |
| Protein Transport | 1 | 2020 | 487 | 0.05 | Why? |
| Tibia | 1 | 2019 | 72 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Tablets | 1 | 2019 | 219 | 0.05 | Why? |
| Enzyme Stability | 1 | 2018 | 72 | 0.05 | Why? |
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 6 | 0.04 | Why? |
| Palladium | 1 | 2017 | 35 | 0.04 | Why? |
| Antigens, Differentiation, B-Lymphocyte | 1 | 2018 | 54 | 0.04 | Why? |
| Streptozocin | 1 | 2017 | 29 | 0.04 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.04 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.04 | Why? |
| Binding Sites | 2 | 2021 | 6201 | 0.04 | Why? |
| Molybdenum | 1 | 2017 | 43 | 0.04 | Why? |
| Hepatic Stellate Cells | 1 | 2017 | 35 | 0.04 | Why? |
| Vinblastine | 1 | 2017 | 48 | 0.04 | Why? |
| Collagen Type I | 1 | 2017 | 56 | 0.04 | Why? |
| Cell-Free System | 1 | 2016 | 23 | 0.04 | Why? |
| Mice, Inbred Strains | 1 | 2017 | 136 | 0.04 | Why? |
| Sulfones | 1 | 2017 | 66 | 0.04 | Why? |
| Endothelial Protein C Receptor | 1 | 2017 | 32 | 0.04 | Why? |
| Protein Binding | 3 | 2020 | 11430 | 0.04 | Why? |
| Carboplatin | 1 | 2017 | 76 | 0.04 | Why? |
| 3T3-L1 Cells | 1 | 2016 | 29 | 0.04 | Why? |
| Actins | 1 | 2017 | 108 | 0.04 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Rhodium | 1 | 2016 | 5 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Disulfides | 1 | 2017 | 161 | 0.04 | Why? |
| Linkage Disequilibrium | 1 | 2017 | 191 | 0.04 | Why? |
| Immunoprecipitation | 1 | 2017 | 300 | 0.04 | Why? |
| Cyclization | 1 | 2016 | 46 | 0.04 | Why? |
| Membrane Microdomains | 1 | 2016 | 51 | 0.04 | Why? |
| Double-Blind Method | 2 | 2019 | 5988 | 0.04 | Why? |
| Adolescent | 5 | 2019 | 86841 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Genomics | 1 | 2009 | 3118 | 0.04 | Why? |
| Stereoisomerism | 1 | 2016 | 121 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2017 | 400 | 0.04 | Why? |
| Host Specificity | 1 | 2020 | 926 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Cisplatin | 1 | 2017 | 209 | 0.04 | Why? |
| Naphthoquinones | 1 | 2016 | 87 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Sequence Homology | 1 | 2017 | 448 | 0.04 | Why? |
| Immunoglobulin Variable Region | 1 | 2016 | 253 | 0.04 | Why? |
| Immunoglobulin Heavy Chains | 1 | 2016 | 222 | 0.04 | Why? |
| Postoperative Period | 1 | 2018 | 651 | 0.04 | Why? |
| GPI-Linked Proteins | 1 | 2016 | 317 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Rodentia | 1 | 2017 | 235 | 0.04 | Why? |
| Histocompatibility Antigens Class II | 1 | 2018 | 383 | 0.04 | Why? |
| Mice, Knockout | 1 | 2020 | 1815 | 0.04 | Why? |
| Polymerase Chain Reaction | 1 | 2010 | 6740 | 0.04 | Why? |
| Thrombin | 1 | 2018 | 325 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2017 | 3776 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.03 | Why? |
| Protein Engineering | 1 | 2018 | 536 | 0.03 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| HIV Envelope Protein gp120 | 1 | 2016 | 267 | 0.03 | Why? |
| Cholesterol | 1 | 2018 | 660 | 0.03 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Chemotherapy, Adjuvant | 1 | 2017 | 606 | 0.03 | Why? |
| Lung | 4 | 2021 | 31049 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.03 | Why? |
| Wound Healing | 1 | 2018 | 424 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Prognosis | 4 | 2018 | 32490 | 0.03 | Why? |
| Rectum | 1 | 2017 | 495 | 0.03 | Why? |
| Thermodynamics | 1 | 2017 | 873 | 0.03 | Why? |
| Organometallic Compounds | 1 | 2016 | 206 | 0.03 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.03 | Why? |
| Haplotypes | 1 | 2017 | 853 | 0.03 | Why? |
| Furin | 1 | 2021 | 1054 | 0.03 | Why? |
| Liver | 2 | 2018 | 4007 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Survival Rate | 2 | 2018 | 9206 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2017 | 704 | 0.03 | Why? |
| Glucose | 1 | 2017 | 573 | 0.03 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.03 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.03 | Why? |
| Immune Sera | 1 | 2017 | 884 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2016 | 680 | 0.03 | Why? |
| K562 Cells | 1 | 2010 | 91 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2018 | 2219 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.03 | Why? |
| Adenocarcinoma | 1 | 2018 | 651 | 0.03 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.03 | Why? |
| Catalytic Domain | 1 | 2017 | 1757 | 0.03 | Why? |
| Myocytes, Cardiac | 1 | 2017 | 804 | 0.03 | Why? |
| Caspases | 1 | 2010 | 156 | 0.03 | Why? |
| Case-Control Studies | 3 | 2017 | 17671 | 0.03 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.03 | Why? |
| Bismuth | 1 | 2010 | 56 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.02 | Why? |
| Vaccines | 1 | 2009 | 3692 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.02 | Why? |
| Gene Products, tat | 1 | 2008 | 7 | 0.02 | Why? |
| Gene Products, pol | 1 | 2008 | 13 | 0.02 | Why? |
| Gene Products, nef | 1 | 2008 | 15 | 0.02 | Why? |
| Gene Products, gag | 1 | 2008 | 28 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Gene Products, env | 1 | 2008 | 74 | 0.02 | Why? |
| Hong Kong | 1 | 2017 | 3361 | 0.02 | Why? |
| Brain | 1 | 2005 | 5133 | 0.02 | Why? |
| Zika Virus | 1 | 2020 | 1924 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Genes, MHC Class II | 1 | 2006 | 48 | 0.02 | Why? |
| Aftercare | 1 | 2017 | 1637 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Genes, MHC Class I | 1 | 2006 | 81 | 0.02 | Why? |
| Protein Conformation | 1 | 2018 | 4386 | 0.02 | Why? |
| Zika Virus Infection | 1 | 2020 | 1920 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 13720 | 0.02 | Why? |
| Conserved Sequence | 1 | 2008 | 751 | 0.02 | Why? |
| Combinatorial Chemistry Techniques | 1 | 2004 | 54 | 0.02 | Why? |
| Proton Pump Inhibitors | 1 | 2010 | 377 | 0.02 | Why? |
| Transfection | 1 | 2008 | 864 | 0.02 | Why? |
| Opioid-Related Disorders | 1 | 2017 | 1185 | 0.02 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Cloning, Molecular | 1 | 2008 | 1036 | 0.02 | Why? |
| Research | 1 | 2017 | 2115 | 0.02 | Why? |
| Nucleocapsid Proteins | 2 | 2006 | 3120 | 0.02 | Why? |
| Gastrointestinal Diseases | 1 | 2019 | 2580 | 0.02 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Antibody Specificity | 1 | 2006 | 1328 | 0.01 | Why? |
| Gene Frequency | 1 | 2006 | 1210 | 0.01 | Why? |
| Molecular Docking Simulation | 1 | 2017 | 6902 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2015 | 4027 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2016 | 11304 | 0.01 | Why? |
| Molecular Structure | 1 | 2004 | 1539 | 0.01 | Why? |
| Immunoglobulin G | 2 | 2017 | 21571 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Drug Therapy, Combination | 1 | 2010 | 7268 | 0.01 | Why? |
| Viral Matrix Proteins | 1 | 2004 | 1243 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2010 | 10649 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2010 | 10083 | 0.01 | Why? |